Patent Yard Sign in
Expired Canadian patentCanada

Polypeptides

CA 2432971 C · Owner: Moller, Mona · Inventors: Gaudernack, Gustav; Saeboe-Larssen, Stein; Eriksen, Jon, Amund

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to polypeptides and nucleic acids DNA encoding , these polypeptides capable of eliciting an immune reaction against cancer methods for generating T lymphocytes capable of recognising and destroying tumour cells, and pharmaceutical compositions for the treatment prophylaxis , or diagnosis of cancer.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 18, 2001 and granted September 4, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 18, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 18, 2001
GrantedSeptember 4, 2012
Term endedDecember 18, 2021
Patent numberCA 2432971 C
Classification (IPC)A61K39/00 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedDec 18, 2001Patent grantedSep 4, 2012Term endedDec 18, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.